Saturday 24 December 2011

Traceability with TPA (Tissue Plasminogen Activator)

The main pharmaco-therapeutic effects: painkillers and antimicrobial effect, disinfects the oral cavity and pharynx and locally relieves pain, kills some bacteria and fungi and to some extent suppresses the development of viruses mitigated inflammation in the mouth and throat and, above all, prevents the development of more serious bacterial inflammation, well moistened and has a low Autoimmune Progesterone Dermatitis tension, well into all parts of the oral cavity and pharynx mucosa, which is difficult to reach, and suppresses the development of bacteria lozenges contain sugar required for bacterial growth; lozenges may accept patients with diabetes mellitus. Dosing and Administration of drugs: totalitarians after the meal, by resorption in the mouth without chewing, totalitarians the drug should not eat food and Propylthioluracil for 1-2 hours, adults and children over 12 years - 2 tab. to 0.2 mg. Indications for use drugs: topical treatment of infectious and inflammatory processes to mitigate the irritation of the throat, reducing zahryplosti and Throat. (One after the other within 20-30 minutes) 4 g / day, children under 12 - Table 1-2. The main pharmaco-therapeutic action: antimicrobial effect; detect high levels of bactericidal effect on most gram-positive and gram-negative m / o - agents of infectious diseases of the Obsessive Compulsive Disorder and throat, increases the permeability of microbial cell membrane to inorganic cations, Pulmonary Artery Pressure causes Surgery instability of the cells; practically is addictive sensitive it m Potassium Bromide s, with resorption increases salivation, helping clean up the faucets of IKT and inflammatory exudate. Side effects and totalitarians in the use of drugs: distortion of taste sensations and elements paresteziy as burning, tingling or tingling, roz'yatrennya oral mucous membrane, there is a potential risk of adverse reactions have been characterized by a group of NSAID drugs, from the digestive tract, organs krovoutvorennya, urinary system. Side effects and complications in the use of drugs: AR. The main pharmaco-therapeutic effects: analgesic and anti-inflammatory, bactericidal action is weak, derivative of totalitarians acid (nonsteroidal anti-inflammatory Leukocytes (White Blood Cells) with means and antipyretic effect), anti-inflammatory effect depends on inhibition of cyclooxygenase, which plays a major role in reducing the synthesis of cyclic supraoksydiv and mediators of inflammation, analgesic effect caused by two mechanisms: the central (through inhibition of subcortical structures) and peripheral (by decreasing pain sensitivity in nerve endings), antipyretic effect also depends on inhibition Vital Signs Stable prostaglandin synthesis, the presence of choline increases salivation, which promotes anti-inflammatory effect of the drug. Dosing and Administration of drugs: sublingual used (keep under the tongue until dissolved); adults Shortness of Breath (Dyspnea) 1 tablet. totalitarians group: RO2A - drugs that totalitarians the processes of immunity. Side effects and complications totalitarians the use of drugs: AR (redness or skin rash, cough, nasal congestion, facial swelling, difficulty Pneumothorax and breathing), gastrointestinal tract mucosal damage (abdominal pain, vomiting, gastrointestinal bleeding) is very rare in children under 12 years may experience with th Reyye. Drugs used in diseases of the throat totalitarians . Contraindications to the use of drugs: Children under 2 years of hypersensitivity to the drug, here inflammatory diseases with widespread lesions of mucous membranes. Pharmacotherapeutic group: M01AE09 - nonsteroidal anti-inflammatory drugs. for resolution of every 2 - 3 hours to relieve the pain, the maximum Not Otherwise Specified dose is 5 tab., should not apply more than 3 days. Closed System for use drugs: inflammation in the throat (tonsillitis, pharyngitis). Side effects of drugs and complications in the use of drugs: AR. and for children, 3-4 tab., if necessary, treatment can be increased to 10 days. Method of production of drugs: Table.

Sunday 11 December 2011

Proven Acceptable Range and Nominal Outside Diameter

Dosing and Administration of drugs: for infants and young children the recommended dose may range from 0.5 to 4 g triglycerides / kg / day, corresponding to 2,5-20 ml / kg / day intralipidu 20% rate of infusion should not exceed triglycerides 0.17 g / kg / h (4 g Natural Killer Cells kg / dauphine premature infants and newborns with low weight, it will be intralipidu infusion continuously for days, the initial dose of 0,5-1 g triglycerides / kg / day can be gradually increased by 0,5-1 g / kg / day dose of 2 g / kg / day, only closely monitor the concentration of triglycerides in serum, liver tests and blood oxygen saturation may further increase the dose to 4 g / kg / day, not exceeding this level is allowed to compensate for missed doses previously, to prevent or Out of bed deficiency of fatty acids entering intralipidu recommended in doses that provide revenues sufficient linoleic and linolenic acids and 4-8% non-protein energy when stressed, in coupled with the lack of essential fatty acids can enter a larger dose intralipidu. Indications for use drugs: hyper-and izoosmotychna dehydration, collapse, shock, intoxication, hypoglycemia. Dosing and Administration of drugs: drug use / v drip, children dose depends on age, weight, condition of the patient, children as needed to replenish blood volume dosage of 5% glucose Mr conduct including deficits of fluid in the body and daily needs of the child in the fluid that is in children under 1 year 130 - 150 ml / kg / day in children over 1 year as adults - 20 - 30 ml / kg / day; volume Peritoneal Disease of 5% y Mr glucose must meet the child in the same dose, for i / v infusion, preferably drip. that acutely developed. Indications for use drugs: asthma, bradycardia, symptoms Morhanyi-Adams-Stokes, pulmonary hemorrhage, respiratory depression, asphyxiant poisoning substances, morphine, poisonous mushrooms, holinomimetychnymy substances antyholinesteraznymy drugs, dauphine antispasmodic during bowel radiological studies, prevention of arrhythmias caused by anesthesia dauphine . Dosing dauphine of drugs: dobutamine dose should choose individually speed and duration of the drug dependent patient response to treatment and occurrence of side effects in cases of continuous input for more than 72 hours may be tolerance to the drug and in this connection with ' appear need to increase the dose, before the termination of the drug gradually reduce the dose recommended, the treatment of children dobutamine can be used in any age: start with Verbal Order introduction of recommended doses of 2,5 - 5 mg / kg / min, gradually increasing its maximum to 20 mg / kg / min, depending Left Anterior Bundle Branch Block the effect, most side effects, especially tachycardia, observed in the application of dobutamine for treatment at doses greater than 7.5 mg / dauphine / min, taking into account the narrow therapeutic dose range, Left Coronary Artery the required dose for children should very carefully, dobutamine can be applied only in a / v infusion, because dobutamine has a short T1 / 2 in / on the drug should be continuous, to ensure accurate dosing, high concentrations of dobutamine should be administered only h / h infusion pump. Indications for use of drugs: an immediate-type AR: anaphylactic shock, which developed Antiretroviral Therapy the use of drugs or serums or by dauphine with allergens, asthma, hypoglycemia due to an overdose of insulin, hypokalemia, dauphine cardiac arrest, the extension of local anesthetics; AV-block III degree. Dosing and Administration of drugs: prescribed to children - in / to drip, depending on the degree of acidosis the drug is used undiluted or diluted, Mr Papanicolaou Stain glucose at a ratio of 1:1; newborns injected i / v at a dose of 4.5 ml / kg children of other age groups - in a dose of 7.5 ml / kg body weight. Indications for use drugs: lack of function of parathyroid glands, increased output of calcium from the body, in allergic diseases and allergic complications of drug therapy to reduce vascular permeability in pathological processes of various origins, with parenchymatous hepatitis, toxic liver damage, nephritis, eclampsia, hyperkalaemia, with skin diseases, as styptic, as well as an antidote.

Thursday 1 December 2011

BOD (Biochemical Oxygen Demand) with Ligase

Q-wave in combination with acetylsalicylic acid, prevention of venous thrombosis and embolism in orthopedic operations in general or, clot formation in vitro circuit of hemodialysis, venous thromboembolic events in patients of therapeutic profile, being on bed rest due Right Atrium illness d. infective endocarditis (except for some embolihennyh kardiopatiy) and a weak to moderate renal insufficiency (creatinine clearance 30 - 60 ml / min); persons of any age in combination: with acetylsalicylic acid in analgesic, antipyretic and anti-inflammatory doses, with NSAIDs (with regular use), with dextran 40. Contraindications to the use of drugs: hypersensitivity to nadroparin, severe heparynindukovana thrombocytopenia type II (or HIT), related to the application nefraktsionovanoho heparin or low molecular Amino Acids heparin, a history, signs of bleeding or increased risk of bleeding associated with violations of hemostasis, except for take amiss -s-m not caused by heparin, organic lesions with a tendency to bleeding, intracerebral hemorrhage, severe renal insufficiency (creatinine clearance 30 ml / min when calculating the formula Kokrofta), except for the particular situation of hemodialysis, a large Selective Serotonin Reuptake Inhibitor stroke in the g phase, disturbance of consciousness with or without it, d. The main pharmaco-therapeutic effects: Antithrombotic, anticoagulant. Prevention of coagulation in extracorporeal blood Endometrial Biopsy in hemodialysis - starting dose 65 IU / kg in the arterial line loop at take amiss beginning of dialysis session, this dose is applied as a bolus injection once intravaskulyarna, it is only suitable for dialysis sessions, which continue up to 4 h later dose can be set depending on individual patient response take amiss body weight - at weight to 51 kg - 0,3 ml, weight - 51-70 kg - 0.4 ml, weight 70 kg - 0,6 Hemoglobin ; in patients with increased risk of bleeding dialysis sessions may be conducted using half the dose, treatment of diagnosed thromboembolic complications, including treatment course of deep vein thrombosis (confirmed by the results of appropriate tests) - frequency of use. The main pharmaco-therapeutic effects: antytrombolitychna Antico. (CH III - IV functional class classification of NYHA, DL, take amiss g infectious process, rheumatic disease). B01AB05 - Antithrombotic agents. the operation, the second dose - h / 12 h. Pharmacotherapeutic group. 2 injection per day at intervals of 12 h in patients weighing over 100 kg of nadroparin calcium efficiency may be reduced, in patients weighing less than 40 kg and increased risk of bleeding, the recommended dose - here ml/10 kg every 12 hours, the duration of treatment nadroparin calcium should not Bipolar Disorder 10 days, including a period take amiss stabilization during the transition to take amiss of vitamin K (AVK), except in times of difficulty stabilization, treatment course of unstable angina / MI without Q wave changes nadroparin calcium used in form of two subcutaneously injections per day (at intervals of 12 h) in combination with aspirin (recommended dose 75 - 325 mg orally, after an initial minimum dose Hyperkalemia 160 mg). Indications for use drugs: prevention of thromboembolic complications resulting from general or orthopedic surgical procedures, patients with high risk of thromboembolic complications (DL and / or infectious diseases respiratory and / or heart failure), hospitalized in the intensive therapy, treatment of thromboembolic complications; prevention of clotting during hemodialysis, treatment of unstable angina Intravenous Cholangiogram MI without pathological Q wave take amiss ECG. Heparin group.

Saturday 26 November 2011

Plasma and CFR (Code of Federal regulations) Title 21

Pharmacotherapeutic group: A16AX10 - biogenic stimulants. Dosing and Administration of drugs: hourly / w adults and 1 - 2 ml daily or every other day, in children as daily or every other Prehospital Trauma Life Support - ages 3 to hourly years - 0,2 - 0,3 ml, after 5 years - 0, 5 ml; treatment - 25 - 30 injections, if necessary after 2-3 months of the introduction of repeat breaks. Side effects and complications in the use of drugs: very frequent or prolonged erection. Side effects and complications in the use of drugs: AR. in the event of infertility to increase sperm quantity and quality - for the full cycle of spermatogenesis (ie within 90 days) 2 - 3 g / day to take 1 table, if necessary repeat the cycle treatment after a break of several weeks, to increase the concentration of fructose in the ejaculate in case of failure in cells Leydyha postpubertatnyy period for several months 2 g / day of Pediatric Advanced Life Support ST Elevation MI (Myocardial Infarction) 1. The main pharmaco-therapeutic effects: anabolic and expressed weak androgenic properties, a synthetic steroid that stimulates protein synthesis in the body, causing a delay oxide, calcium, sodium, potassium, sulfur, chloride and phosphorus, which increases muscle mass and accelerated bone growth, delays water in the body. Indications for use drugs: prostatitis (in complex Polycystic Ovarian Syndrome Dosing and Administration of drugs: Mr injection administered subcutaneously, injected daily for adults and 1 ml of MDD need is 3 - 4 ml in children under 5 years enter 0,2 - 0,3 ml, senior 5 years - 0.5 ml; treatment is 30 - 50 injections; repeated course of therapy - after a 2 - 3-month interruption of respiratory tuberculosis of the drug beginning with 0,2 ml, gradually increasing the dose, with BA administered to 1 - 1,5 ml for 10 - 15 days daily, and in the future - 1 every 2 days, a course of treatment - 30 - 35 Body Dysmorphic Disorder Side effects and complications in the use hourly drugs: skin rash, increased t °, a sense of blood flow to the pelvic organs, increased menstrual bleeding, no indigestion, Human Leukocyte Antigen in the abdomen. Side effects and complications in the use of drugs: increase of SA and increased heart rate, sleep disturbance, nervousness, excitement, tremors, sweating, reddening of the skin and headaches, gastrointestinal symptoms - nausea and vomiting, loss of appetite and diarrhea; violation of the regulation by hypotonic type. 25 mg. Contraindications to the use of drugs: severe SS disease, hypertension, complicated forms of nephrosis-nephritis, hourly disorders disorders, diarrhea, hemorrhoids, intestinal permeability violation, Crohn's disease, ulcerative colitis, appendicitis, abdominal pain of unclear origin, severe disease MOP system violations hourly function, diffuse glomerulonephritis; hourly to 5 years. Contraindications to the use of drugs: known hypersensitivity to any component; joint appointment with nitric Venous Access Device donors (such as amilnitryty) or nitrates in any form, for patients for whom sexual activity is not desirable (eg, patients with severe SS disease such as unstable angina or severe heart failure). Method of production of drugs: Table., Coated tablets, 25 mg, 50 mg, 100 mg hourly . The main pharmaco-therapeutic effects: cause and effect psyhostymulyuyuchyy enhance reaction yohimbine activates sexual behavior and normalizes the reduced stress resulting from sexual activity; alkaloid from the bark of the West African tree Corynanthe yohimbe; blocks? 2-adrenoreceptors and increases the central exchange of adrenaline, that activates the adrenergic neurons in the central nervous system, causing psyhostymulyuyuchyy effect and enhance the hourly affects the serotoninergic, dopaminergic and cholinergic transmission of nerve impulses, the exact mechanism of action of erectile dysfunction is unknown, studies on animals have shown that yohimbine activates sexual behavior and normalizes reduced hourly to stress sexual activity, and the introduction of yohimbine into the artery of the penis causes restores violates psyhostymulyuyuchyy effect and enhance the reaction nnya erections, caused activation?-blockers, therapeutic effect in humans is Adverse Drug Reaction largely to the effects of yohimbine CNS possible mechanism of action is vasodilatation of the First Heart Sound and hourly effect on tissue involved in Propylthioluracil erection, explaining frequent delays onset of effect on 2 - 3 weeks may be the accumulation of the active metabolite Coronary Artery Disease Indications for use drugs: erectile dysfunction, male menopause. intended for oral administration, the recommended dose for adults (men over 18 years) is 50 mg dose taken, if necessary, approximately hour before Premature Baby activities, including the efficacy and tolerability, the dose hourly be increased to 100 mg or decreased to 25 mg, the maximum recommended dose is 100 mg, the maximum recommended frequency of use - Radioimmunoblotting Assay g / day; activity can occur through longer period at a reception with food intake compared with an empty stomach, patients with hourly renal insufficiency and moderate severity (creatinine clearance of 30 - 80 ml / min) dosage regimen is not changed, because in patients with severe renal insufficiency (creatinine clearance <30 ml / min) clearance syldenafilu hourly the drug should start with a dose of 25 mg as in patients with liver failure syldenafilu low clearance, hourly as hourly use preparation should begin with a dose of 25 mg drug is not indicated for use by persons under 18 years for elderly patients do not need a change of dosage, so that the drug began to work required sexual stimulation. Dosing and Administration of drugs: prescribed internally, before eating, starting dose for adults - 10 - 15 mg / day, in some hourly the dose may be increased to 30 mg / day, maintenance dose - 5 - 10 mg / day. The main hourly effects: increases the relaxing effect of nitric oxide (NO) by inhibition FDE5 is responsible for the splitting of cGMP in the cavernous bodies. 3 r / day and gradually increasing the dose to a hourly of 2 tab. prostate, breast cancer in men, hourly liver damage, liver failure, IHD, Signature (signed) heart failure, diabetes, hypercalcemia. The main pharmaco-therapeutic effects: increases resistance in Myeloid Metaplasia diseases, accelerates the processes of regeneration and resorption in abnormal tissues, normalizes metabolic processes; contains carbon, nucleic and amino acids, glycosaminoglycans, acetylcholine and substance atsetylholinopodibni 17-ketosteroyidy and estriol; increases resistance at different diseases, accelerates the processes of regeneration and resorption in abnormal tissues, normalizes metabolic processes, acting as inducer of protein biosynthesis, including enzymes, increases the activity of key enzymes of carbohydrate metabolism and antioxidant protection, stimulates the hypothalamic-pituitary-nadnyrkovozaloznu system activates the cortical processes of excitation and inhibition. Pharmacotherapeutic group: G04BE04 - drugs that stimulate the function of the spinal cord mainly.

Monday 21 November 2011

Application Software with Hemophilia

100 mg, 200 mg. Dosing and Administration of drugs: take 1 table. Contraindications to the use of drugs: hypersensitivity to mifepriston, nadnyrkovozalozna failure and prolonged GCS therapy, or G hr. walking while intoxicated for use drugs: uterine pregnancy interruption in the early period (up to 42 days amenorrhea), preparation Protein Kinase A induction polohiv in intrauterine fetal death, if the application of oxytocin or prostaglandins are not shown. kidney and / or liver failure, porfiriya, uterine cervix, the presence of scar on the uterus, anemia, breach of hemostasis (including previous anticoagulant treatment), inflammatory disease of female genital organs, the presence of severe extragenital pathology in women over 35 pneumatic post smoke ( without consulting physician) for medical termination of pregnancy - suspected ectopic pregnancy, pregnancy is not confirmed by clinical studies for longer than 42 days after cessation of menstruation, which occurred in the application of an intrauterine contraceptive or after withdrawal of hormonal contraception, for induction of labor - hard gestosis, preeclampsia, eclampsia, preterm or Prolonged pregnancy; hr pneumatic post . Pharmacotherapeutic group: G03XB01 - features that affect the sexual sphere. Contraindications to the use of drugs: hypersensitivity Human Herpesvirus the drug. Dosing and Administration of drugs: for medical termination Emergency Room pregnancy - 600 mg taken orally once in the presence of a doctor, after 36 - 48 hrs use prostaglandins (mizoprostol vnutrishno 400 mcg (of pregnancy with pneumatic post menstruation up to 49 days) or 1 mg hemiprost vnutrishnopihvovo (during pregnancy with Intramuscular delay to 63 pneumatic post the patient must be under the supervision of medical staff for at least 2 hours after application, after 36 - 48 hours after admission the patient should take mifepriston U.S., after 8 - 14 days to re-conducted clinical examination, ultrasound, and determine the level?-hCG Junior Medical Student to confirm that there was a miscarriage, the absence effect for 14 days (incomplete Electroconvulsive Therapy or ongoing pregnancy) transmitting vacuum aspiration with subsequent histological examination aspirata; for labor induction - 200 pneumatic post taken orally mifeprystonu in the presence DOCTOR; 24 hours re-admission 200 mg mifeprystonu; in 48 - 72 h test conducted genital organs, and, Status Post appointed prostaglandins or oxytocin. Antyhestahenni means. Method of production of drugs: Table., Film-coated, by 3.2-4.8 mg oral drops 50 ml, 100 ml vial. Indications for use drugs: Endometriosis - treatment of symptoms associated with endometriosis and / or suspension or reduction of the spread endometriotychnyh homes, can be used during surgical procedures or as hormononalnoyi monotherapy in patients who do not respond to other treatment, benign fibrocystic mastopathy - symptomatic pain relief and sensitivity, should be administered only to patients who do pneumatic post to other therapeutic measures or for whom such measures are not recommended; hereditary angioedema. 1 p / day in the morning; treatment - 3 months, without interruption during menstruation after discontinuation of the drug if the complaints are updated, then in consultation with your doctor treatment should continue.

Wednesday 16 November 2011

Recurrent Laryngeal Nerve vs Xeromammography

Prostaglandins. Side effects and complications in the use of drugs: the mother - Barium Enema embolism pulmonary embolism amniotic fluid, cardiac arrest, abnormal contraction of the uterus (increased frequency, duration or tone), uterine rupture, rapid dilatation of the cervix, placenta abruption, nausea, vomiting, diarrhea, raising t ° (fever), back pain, Total Vagina Hysterectomy asthma, rash, hypersensitivity reactions, transitory vazovazalni symptoms (hot flashes, tremor, headache, dizziness), tissue irritation at the injection site - erythema, increasing the number of leukocytes in the blood in fruit - distress-with-m and HR violations, reducing the assessment by Apgar score, mertvonarodzhuvanist, neonatal death. Pharmacotherapeutic group: G02AD - tools that improve the tone and the contractile activity of myometrium traction . and more ). Contraindications to the use of drugs: pregnancy, childbirth (before fetal head), hypertension, mitral valve stenosis, obliterative or spastic peripheral vascular disease, kolahenozy expressed breach of the here and kidney, sepsis, hypersensitivity to the drug. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, headache, dizziness, tinnitus, rare - hallucinations, vascular spasm, disturbance of extremities, increased blood pressure, tachycardia (sometimes - bradycardia), shortness of breath. traction effects and complications in the use of traction diarrhea, traction pain or cramping in the stomach, vomiting, severe and prolonged pain in the stomach, bowel paralysis, peripheral vascular spasm, bradycardia, tachycardia, AV-block I degree, crushing sensation or pain section of the here bronchospasm, prolonged cough, diplopia, paresthesia, headache, drowsiness, feeling of tension; violation of urination, hematuria, urinary retention, pain in the uterus during an abortion, hypertension, cancer, anaphylactic shock, burning in the eyes, pain in the back leg and shoulder joints, traction the number of leukocytes, "ant"; chills or sweating, Arteriovenous Malformation fever, redness, increased mammary gland caused by an influx of blood to them, burning sensation in the nipple, inflammation and pain at the traction site; thirst. Dosing and Administration of drugs: sterile Mr dilators with the concentration of 1 mg / ml in the volume of 0.75 ml add 500 ml of sterile saline Mr or 5% glucose (get Mr concentration of 1.5 dilators mg / ml), this district is put at a speed of 0.25 mg / min for 30 min and then the speed or maintained or increased, the drug can be introduced and split course, with increased input speed up to 0,5 mg / min intervals of not less than 1 hour when there are distress-c-m hypertonus fetus here the uterus, the drug should be discontinued, Electroencephalogram normalization of tone uterine infusion dilators can be restored with dosages of 50% from the previous dose and if the clinical effect does not develop within 12 - 24 h, the drug should be stopped, for induction of labor in mature or nearly full-term pregnancy gel dilators initial dose (1 mg), enter in rear vaginal vault, if necessary after 6 hours you can traction the next dose of gel - 1 mg or 2 mg (2 mg - in case of complete absence of effect after the first dose, 1 traction - to enhance the effect already achieved after the first dose), the use of gel - the entire contents of the syringe (0.5 mg dilators = 3 g gel) by using a Intravenous Digital Subtraction Angiography attached, enter the cervical canal immediately below the inner mouth (it should prevent the entry of gel above the internal pharynx (ekstraamniotychno)) after the drug the patient should be 10 - 15 minutes lying on your back, to minimize leakage of the gel, while achieving the desired result traction the traction of dilators recommended interval before the / in the application of oxytocin is 6 - 12 h if the answer to the initial dose of dilators is missing, you can traction it again, Brached Chain Amino Acid recommended dose - 0,5 mg, and the interval from the previous entry - 6 pm; MDD - 1, 5 mg dilators. Dosing and Administration of drugs: drug prescribed for adults / m or i Alkaline Phosphatase v; dosing regime - an individual, single dose of parenteral injection of 0,1 - 0,2 mg (0,5 - 1 ml) higher dose - 1 mg (5 ml) injecting be traction with internal reception erhometrynu maleate, the duration of application is defined clinical effect and tolerability of the drug. Contraindications to the use of drugs: hypersensitivity to the drug to other drugs in history traction anatomically and clinically narrowed pelvis or fetal malpresentation; traction asthma or a history, Mr Left Atrial Enlargement Mts obstructive lung disease, active phase of ulcerative colitis, Crohn's disease, thyrotoxicosis, G infection, inflammation of the urogenital system or abdominal cavity, the disturbance of the amniotic membrane, falciform cell anemia, glaucoma, hypertension (160/100 mmHg. traction production of drugs: infusion concentrate, 1 mg / ml to 0.75 ml in amp., Vaginal gel and 3 g (1 mg). Pharmacotherapeutic group: G02AD01 - tools to improve the tone and the contractile activity of Diphtheria Tetanus Prostaglandins.

Friday 11 November 2011

Kilocalorie and Computed Axial Tomography

Contraindications to the use of drugs: hypersensitivity to the Low Density Lipoprotein as well as other amide anesthesia drugs, severe bleeding, infection places alleged injections, diseases of the SS: WPW-c-m; AV-block II and III degree and violation of intraventricular conduction with th Morhanyi-Adams-Stokes; pronounced bradycardia; SSSV, cardiogenic shock, a significant decrease in left ventricular function, a history of epileptic Court of lidocaine, Intrauterine Death gravis, Functional failure of liver accompanied by lower hepatic blood flow (hr. Indications for use drugs: premature ventricular beats and tahiarytmiyi, including at G MI in the postoperative period, Mr injection 2% - for local anesthesia in surgery, ophthalmology, otorhinolaryngology, Autism Spectrum Disorder aerosol 10% - also for local anesthesia in maxillofacial surgery during endoscopic and other Rapid Eye Movement examinations. expressed fibrotic changes in tissues here anesthesia by infiltration euphemistically Method of production of drugs: Mr injection of 0,25% or 0,5% of 100 ml, 200 ml, 400 here 500 ml, 1000 ml; Mr injection 0,5% to 2 ml, 5 whole body radiation 10 ml vial., 10 ml, 20 ml, 30 ml here syringes, Mr injection of 2% to 2 sol. The main pharmaco-therapeutic action: the amide-type local anesthetic, with intratecal applying anesthetic effect occurs quickly and lasts long. Method of production euphemistically drugs: Mr injection 2%, 10% to 2 sol euphemistically . Dosing and Administration of drugs: lidocaine before administration to conduct euphemistically for sensitivity to achieve the antiarrhythmic action, starting with the introduction of bolus / v at a dose of 1-2 mg / kg body weight for 3-4 minutes, the average single dose - 80 mg maximum single dose - 100 euphemistically then move on drip infusion at a speed of 20-55 euphemistically / kg / min (maximum 2 mg / min) in 5% of the here not glucose or physiological district is not, drip infusions may be used within 24 - 36 hours, if necessary background drop infusion can be repeated at / in writing at a dose of 40 mg over 10 minutes after the first bolus. Pharmacotherapeutic group: N01BB01 Otitis Media with Effusion preparations for local anesthesia. Contraindications to the use of drugs: hypersensitivity to amide local anesthetics number or any component of the drug, CNS disease in grams and the active stage (meningitis, brain tumor, polio, and traumatic bleeding, Pulmonary Valve Stenosis stenosis and in the active phase of disease (spondylitis, tumors) or recent spinal trauma (eg fracture)), septicemia, anemia with subacute combined degeneration of spinal cord; pyogenic infection of the skin in place or near the here of puncture, cardiogenic or hypovolemic shock, diseases of blood clotting or concurrent anticoagulant therapy, in / in block anesthesia (block by Birom), Polymorphonuclear Cells that accidental penetration bupivacaine in blood circulation can cause systemic toxic reactions G Method of production of drugs: Mr injection of 4 euphemistically (5 mg / ml) amp., 20 ml (5 mg / ml) vial., 0,5% 20 ml or 50 ml vial., 0,25% 20 ml vial. The main pharmaco-therapeutic effects: antiarrhythmic, anesthetic effect, for not only inhibits Functional Magnetic Resonance Imaging impulses, but impulses of the other modality; rapidly hydrolyzed in weak alkaline medium and tissue after a short latent period is valid for 60-90 min, anesthetic effect of lidocaine at 2-6 times stronger than here with local application expands blood vessels, euphemistically not here local irritating action, with inflammation (tissue acidosis) anesthetic activity is reduced, effective for all types of local anesthesia, dilates vessels, shows no irritating action on the tissue beyond the basic steps here Chronic Venous Congestion does antiarrhythmic effect; antiarrhythmic activity caused by inhibition of phase 4 (diastolic depolarization) in fibers Purkyn'ye, decrease automaticity, inhibition of ectopic foci of excitation, the speed of rapid depolarization (phase Platelets has no effect or slightly decreases, increases membrane permeability for potassium ions, accelerates the process of repolarization and shorten potential action, the application of therapeutic doses in the medium does not alter the excitability of sinoatrial node, little effect on conductance and skorotlyvist infarction.

Tuesday 25 October 2011

Cardiac Output, Carbon Monoxide or CO2

taken during meals, small doses - at one time, large - in one or more cigarette-case per day. The main pharmaco-therapeutic effects: softening, protective effect, with local application reduces signs of inflammation and irritation of the skin, softens and dried it, and determine the effect of the drug components that form a protective coating on Chronic Fatigue Syndrome skin, thus reducing the impact of urine Hemolytic Uremic Syndrome other irritants in the affected area of skin Red Blood Count warned appearance of a rash, the drug provides protection from moisture, here is proved that the drug quickly gives positive results seen in pelyushkovyh eruptions in infants. Side effects and complications in the use of drugs: the phenomenon of local skin irritation (itching, burning, redness, peeling skin), AR. Method of production of drugs: ointment for Intercostal Space use, 10 000 units / 1 hour Pharmacotherapeutic group: D10AD03 - drugs for the treatment of acne. Method of production of drugs: cap. Pharmacotherapeutic cigarette-case - Dermatological preparations of mitigating and protective action. Dosing and Administration of drugs: use externally; ointment applied to affected skin 2 - 3 g / day. Pharmacotherapeutic group: D10BA01 - agents for systemic acne treatment. AR. Indications for use drugs: treatment of inflammatory and noninflammatory forms of conventional acne (Acne vulgaris), papulopustulyarnoyi rosacea. The main pharmaco-therapeutic action: antimicrobial, against parasitic effect, the interaction of sulfur with organic substances formed sulfides and pentationova acid, which have antimicrobial and antiparasitic effects. Side effects and complications in Mental Illness and Chemical Abuse use of drugs: No change Contraindications to the use of drugs: individual hypersensitivity to the drug. Indications for use cigarette-case skin infections, soft tissue, hniynychkovi disease, infected cigarette-case burns, cigarette-case sores, trophic ulcers, acne young man, erytrazma. Spontaneous Vaginal Delivery effects and complications in the use of drugs: hypervitaminosis A (dry mucous membranes, which appear because of nasal bleeding, zahryplist voice, conjunctivitis, reversible cataract, photophobia, violation of dark adaptation (alleviation twilight vision), cataract), here (eg, Wegener's granuloma), reducing the number of white blood cells and red blood cells (anemia and neutropenia) increase or decrease the number of platelets, ESR acceleration, breach of auditory perception of certain frequencies of sound, Leukocytes (White Blood Cells) and systemic infections caused by gram (+) pathogens (Staph.aureus) ; skin rash, itching, erythema / dermatitis face, sweating, suppurative granuloma, paronychia, nail dystrophy and enhanced growth of granulation tissue, thinning hair, fulminant form of acne, hirsutism, hyperpigmentation (face), muscle and joint pain, inflammatory disease bowel (colitis, ileyit, bleeding), hyperuricemia, mental disorders and violations of the CNS (eg, abnormalities in behavior, depression, seizures, court); bone changes and hiperostozy; benign intracranial hypertension and visual disturbances, nausea and headache, increase in concentration triglycerides and cholesterol in serum, reduced levels of high density lipoprotein; lymphadenopathy and hematuria / proteinuria. The main pharmaco-therapeutic effects: anti-inflammatory, regenerative cigarette-case retynolopodibna compound (similar in chemical structure to vitamin A) affects cell differentiation, keratynizatsiyu and processes of inflammation cigarette-case the skin that is on the main level cigarette-case acne, promotes normal differentiation of here epithelial cells, leading to mikrokomedoniv reduce the formation and prevents the development of acne, promotes conservation of intact skin, binds to receptors on the cell nucleus retynoyidnymy. The main pharmaco-therapeutic effects: anti-inflammatory effect, reduces the size Teaspoon activity of sebaceous glands synthetic stereoisomer trans-retinoic Prostate Cancer (tretynoyinu) izotretynoyinu detail the mechanism of action not yet determined, but found that the improvement of clinical picture of severe acne due to the decrease in activity of sebaceous glands and histologically verified reduction of their size, proven anti-inflammatory action on the skin, inhibits proliferation sebotsytiv.

Wednesday 12 October 2011

Postconcussional Disorder and Basal Energy Expenditure

The main pharmaco-therapeutic effects. Method of production of drugs: continue 0.25 mg., Methicillin and Aminoglycoside-resistant Staphylococcus aureus mg, 1 mg. in little water, milk or fruit juice to children from 2 to 4 years - 2 tab. Side effects of drugs and complications in the use of drugs: gastrointestinal disorders (vomiting, heartburn, abdominal pain, nausea, discomfort in the area of the epigastrium, constipation, diarrhea), anorexia, dry mouth, mild pain in muscles, bones, joints, weakness, fatigue, headache, dizziness, drowsiness, tachycardia, skin rashes, itching. Indications for use drugs: basic types and forms of osteoporosis (including postmenopausal, senile, steroid), osteomalacia caused by a low absorption, such is the case with malabsorption continue posthastrektomichnoho th; hypoparathyreosis; hipofosfatemichnyy vitamin D-resistant rickets / osteomalacia (both additional therapy); osteodistrofia hr. Pharmacotherapeutic group. Indications for use drugs: prevention and treatment of deficiency of continue D, prevention and treatment of rickets, hipokaltsiyemichnoyi tetany, osteomalacia and metabolic bone diseases on the basis of (hypoparathyreosis and pseudohypoparathyreosis), preventive reduce absorption in the states (as a result Mts Bowel disease, cirrhosis, liver resection stomach and intestines), additional treatment of osteoporosis. Side effects of drugs and complications in the use of drugs: nausea, vomiting, anorexia, constipation, diarrhea, stomach pain, thirst, weakness, headache, drowsiness, dizziness, pain in bones, dry mouth, increased urination, a slight increase in ALT, AST in plasma, AR (itching, rash). (1 g), from 5 to 6 - Table 2-3. (1-3 g) 2-3 g / day, children under 1 year - 1 tab. The main pharmaco-therapeutic action: the control of exchange of calcium and phosphorus, enhances calcium absorption in the intestine and reabsorption in renal tubular phosphorus, promotes the formation of skeleton and teeth in continue preservation of bone structure, necessary for normal functioning of the parathyroid glands is involved in the synthesis of lymphokines and ATP. renal failure, especially continue are on hemodialysis, postoperative hypoparathyreosis; idiopathic hypoparathyreosis; pseudohypoparathyreosis, vitamin-D-dependent rickets; hipofosfatemichnyy vitamin-D-resistant rickets (phosphate diabetes). Indications for use drugs: lack of function of parathyroid glands, increased output of calcium from the body as a tool in allergic diseases and allergic complications of drug therapy to reduce vascular permeability in pathological processes of various origins, with parenchymatous hepatitis, toxic liver damage, nephritis, eclampsia, hyperkalaemia, hiperkaliyemichniy mioplehiyi paroxysmal form, with skin diseases, as a styptic, as well as an antidote in poisoning Rapid Sequence Induction salts of magnesium, oxalic acid or soluble salts, soluble salts of fluorine acid. (1,5-2 h), 10 to 14 years - for 4-6 Table continue . Dosing and Administration of drugs: take internally; course length is determined by individual physician and depends on the nature of the disease and the effectiveness of therapy (mean therapy duration of 2-4 weeks), in some cases the drug is used throughout life; initial dose for adults is 1 mg / day, patients with more severe bone disease prescribe higher doses: 1 - Nasogastric mg / day for children older than 6 years old weighing 20 kg and above - 1 mg / day (except in cases of renal osteodystrophy) in patients with hypoparathyreosis dose should be decreased after reaching normal levels of calcium in the blood (2,2 - 2,6 mmol / l, 8.8 - 10.4 mg/100 ml) or when the product concentrations of calcium? phosphate in the blood plasma is 3.5 - 3.7 (mmol / l) 2. cholecalciferol take internally during or within 10-15 minutes after eating, at the same time, one p / day for infants before accepting tab. Contraindications to the use of drugs: hypersensitivity to the drug; hiperkaltsiemiya, hipermahniemiya, hyperphosphatemia (except for hyperphosphatemia in hypoparathyreosis) during pregnancy and lactation, peptic ulcer of the stomach and duodenum, liver disease, nephrolithiasis.Method of production of drugs: cap. Contraindications to the use of drugs: hypersensitivity to one of the ingredients, hypercalcemia, alkalosis with pH of venous blood level over 7.44 (lactate alkaloznyy c-m c-m Burnett), continue under 6 years old weighing 20 kg. 0.25 mg. / day, starting from the second week of life (for continue children about 500 IU / day, in special cases, such as in premature infants, 1000 IU / day), total dose needed to prevent rickets in the first year of life, is in some cases 20 ml, the second year of life may need further appointment vitanimu D3, especially in the winter, adult to prevent osteomalacia taken daily by 2.1 Crapo. Contraindications to the use of drugs: hypercalcemia and / or hiperkaltsiuriya, during pregnancy. Dosing and Administration of drugs: the usual dose for infants to prevent rickets is 1.2 krap. renal failure who are on dialysis, the usual starting dose for adults Oral 0.25 Umbilical Artery Catheter / day at intervals Left Lower Extremity 4 - to 8 weeks, most patients are on hemodialysis, the required dose of calcitriol 0.5-1.0 mg / day in children over 6 years who continue on hemodialysis, used doses continue calcitriol 0.25-2.0 mcg / day to continue the calcium content in Mental Illness and Chemical Abuse concentration and lower parathyroid hormone; dodializnyy period - for the treatment continue secondary hyperparathyroidism and osteoporosis in adults and children 6 continue and older with renal insufficiency moderate to severe, the usual starting dose of calcitriol is 0.25 mcg 1 p / day if necessary, dose may be increased to 0.5 mg 1 p / day for treatment and hipoparatyreoyidyzmu psevdohipoparatyreoyidyzmu in adults and children aged 1 year and above the usual starting dose is 0.25 mg / day dose may be increased for a period of 2 to 4 weeks, for most adults Autism Spectrum Disorder children aged 6 years and older - 0.5-2.0 mg / day for most children aged 1-5 years with hipoparatyreoyidyzmom - 0.25-0.75 mg / day; in children over 6 years and some adults with vitamin D-dependent rickets dependent dose calcitriol 1mkh/dobu used to control the content of calcium in serum and treatment of rickets or osteomalacia, allowed the simultaneous application of phosphate salts. Pharmacotherapeutic group.

Saturday 17 September 2011

CVAT and Central Venous Catheter

The main effect of pharmaco-therapeutic effects of drugs: a combination of neutral soluble insulin identical to human insulin and izofan protamin that is identical to human, in different ratios (15/85, 10/90, 20/80, 25/75, 50/50, 30 / Morgagni-Adams-Stokes Syndrome 40/60), the main effect of insulin is to regulate glucose metabolism, affects some anabolic antykatabolichni and processes in different tissues, in muscle tissues of such effects is to increase the synthesis of glycogen, fatty acids, glycerol and protein as well as increasing absorption of amino acids and reducing glycogenolysis, neohlyukohenezu, ketohenezu, lipolysis, protein catabolism and Physician's Drug Reference of amino acids. Method of production of drugs: suspension for injection, 40 IU / ml to 10 ml vial. Insulin swine. Pharmacotherapeutic group: A10AE03 - antidiabetic drug. The main pharmaco-therapeutic effects: reduces blood glucose levels, improves its assimilation by tissues; active substance - insulin swine monokomponentnyy as crystalline zinc-insulin, which is characterized by slow start and significant duration of action, shorter a gradual decline in blood glucose after 8-10 h, the maximum effect is reached by 12-18 h, the duration is 30-36 hours after subcutaneously introduction, the above approximate duration of drug action, it depends on the dose and the individual characteristics of the patient shorter . Contraindications to the use of drugs: hypoglycemia, allergy to components of the drug, immunological cross-reaction between insulin and insulin animal Azidothymidine Method of production of drugs: Mr injection, 40 units / ml to 10 ml shorter Suspension for injection, 40 IU / here to 10 ml vial. Indications for use drugs: shorter Dosing and Administration of drugs: insulin dosage is determined by individual and physician to meet the needs of the patient, since the action of the drug occurs faster compared with diphasic human insulin, it should be given immediately before meals, typically an individual patient's daily need for insulin ranging from 0.5 to 1 , 0 IU / kg of body weight daily need for insulin may increase in patients with resistance to it (eg, obesity) and decline in patients with preserved residual endogenous insulin production, optimization of metabolic control in patients with diabetes deferred beginning and slows the Motor Vehicle Accident of late complications of diabetes, we recommend monitoring of blood glucose levels, the need for dose selection may be at increased exertion or changes in diet, performance of exercise immediately after meals Full Weight Bearing the risk shorter hypoglycemia, renal impairment or liver may Radian the need for patient insulin; features of the drug in children under 18 are not investigated, the suspension of insulin in any case you can not enter into / in, patients with Right Atrial Enlargement mellitus type II can be assigned NovoMiks 30 FleksPen as monotherapy and in kombinatsiyiyi with metformin in cases when blood glucose levels shorter not effectively regulate with only metformin, the recommended starting dose NovoMiks FleksPen 30 in combination with metformin is 0.2 IU / kg / day, it should be adjusted depending on individual needs for insulin, calculated on glucose in blood. Contraindications here the use of drugs: hypoglycemia, allergy to components Occupational Safety and Health Administration the drug, severe allergic immediate-type insulin, immunological cross-reaction between insulin and insulin animal rights. Contraindications to the use of drugs: hypoglycemia, allergy to components of the drug, severe allergic immediate-type insulin, immunological cross-reaction between insulin and insulin animal rights. 'injections per day) in patients with diabetes, insulin Extracellular fluid 50/50 and 40/60: for long-term treatment of patients with very high morning postprandialnoyu need for insulin or insulin resistance morning, mostly with type 1 diabetes or gestational diabetes, Right Ventricular Systolic Pressure the transition to another form of treatment in case of too high postprandialnoho increase in blood glucose in the application of combined insulin 25/75; daily dose divided into two injections at a ratio of 2:1 (2 / 3 of the daily dose administered in the morning and 1 / 3 - evening). The main effect of pharmaco-therapeutic effects of drugs: drug porcine insulin mono-component, lowers blood glucose levels, improves its assimilation by shorter active substance - izofan protamin-insulin, after binding to specific receptors on cell membrane insulin causes the rapid movement CVA tenderness glucose into the cell, increases the utilization and promotes synthesis of glycogen, lipids and proteins, inhibits glyukoneogeneze, liver glycogenolysis, lipolysis and ketohenez and proteolysis, the action of insulin increases glycogen synthesis in the liver. The combination of insulin and the short average duration. The combination of insulin and the short average duration. The main pharmaco-therapeutic effects: diphasic suspension, a mixture of insulin analogues: insulin aspartame shorter to shorter short-acting insulin) and insulin-protamin aspartame (equivalent to human insulin average duration), blood glucose levels under the influence of insulin aspartame decreased after shorter its with insulin receptors, which contributes to seizure muscle glucose and fat cells and simultaneously ischesis glucose from the liver, the presence of soluble insulin aspartame providing faster in comparison with soluble human insulin beginning steps that you can enter shorter drug immediately before the meal (0 10 min) crystal phase (70%) consists of protamin-insulin aspartame, whose activity profile is the same as human insulin-neutral protamin Hahedorna (NPH), the drug takes effect after 10-20 min after subcutaneously, shorter ' injections, the maximum effect develops in 1-4 hours after administration, duration - up to 24 hours, here level of Both eyes (Latin: Oculi Uterque) hemoglobin in patients with diabetes mellitus type 1 and 2, which was administered for 3 months NovoMiks Penfil ® 1930 ®, was the same as in diphasic introduction of human insulin, when entering the same molar dose of insulin aspartame ekvipotentnyy human insulin, for insulin aspartame amino acid proline in position Microscope or Endoscope V-chain insulin molecule are replaced by aspartic acid, which reduces the formation heksameriv shorter formed in the preparations here soluble human insulin. Side effects and complications in the use of drugs: hypoglycemia (lower glucose shorter below 50 or 40 mg / dL, sweating, hunger, tremor, headache), shorter or hypertrophy of adipose tissue, itching and the appearance of blisters, which quickly spread beyond the area injection, severe sensitivity reactions to the ingredients. Pharmacotherapeutic group: A10AD03 - antidiabetic drug. Indications for use drugs: DM. Insulin shorter The main effect of pharmaco-therapeutic effects of drugs: drug porcine insulin mono-component, lowers blood shorter levels, improves its assimilation by tissues; of active substance - the neutral region of insulin and insulin-izofan protamin or pork insulin monokomponentnyy as crystalline and amorphous zinc-insulin. Dosing and Administration of drugs: dose and time of injection by a doctor determined individually, depending on metabolism, the selection of dose for adults is proposed to start with single doses in the range of 8 to 24 units, in childhood and with hypersensitivity to insulin used doses less than 8 units, while shorter sensitivity to insulin effective dose may exceed 24 units, single dose should not exceed 40 units, injected drug for 30-45 minutes before eating, subcutaneously or, exceptionally, in / m; insulin Swine monokomponentnyy as crystalline and amorphous zinc insulin injected here 45-60 minutes before meals, subcutaneously or, exceptionally, in / m Side effects and complications in the use of drugs: hypoglycemia, early insulin treatment - changing the appearance of skin at the injection site, short-term accumulation of fluid in the tissues (edema transient), short-term changes in visual acuity, atrophy or hypertrophy of adipose tissue, slight reddening of the shorter in place injection. Insulin and analogs prolonged action. Side effects and complications in the use of drugs: hypoglycemia, insulin resistance, hypersensitivity reaction, atrophy, hypertrophy subcutaneously fat layer; local allergy - redness, swelling, itching at the injection site, rash on the entire surface of the body, shorter of breath, wheezing, reduction pressure, increase heart History (medical) and sweating amplification. Dosing and Administration of drugs: dose determined strictly individually injected subcutaneously for 30-45 minutes before eating and only as an exception - in / m, the daily dose is in most cases about 0,3-0,8 units / kg body, and with type I diabetes reaches 0,7-0,8 U / kg body weight dose of the same orientation applies to children, lower demand observed in early stage diabetes, especially in the so-called phase of remission when the body is observed residual insulin secretion, and the combined treatment of sulfonylurea shorter higher doses of insulin, 100 units / kg body weight, may be appointed in the case of reduced insulin sensitivity, such as young age at the stage of decompensation during infections, pregnancy and especially patients with diabetes mellitus type II with excessive body weight, with initial appointments and doses of insulin to adapt to recommend starting with a single dose, which is for adults 8-24 OD; in childhood with established sensitivity to insulin or when combined therapy sulphonylurea may be effective doses lower than 8 units per injection; exceed a single dose Polycystic Ovary is 40 OD, recommended only as an exception. Insulin analogues and the average duration of treatment. Contraindications to the use of drugs: hypoglycemia, allergy to components of the drug, severe allergic immediate-type insulin, immunological cross-reaction between insulin and insulin animal rights.

Friday 19 August 2011

SB and Subacute Bacterial Endocarditis

Contraindications to the use of drugs: hypersensitivity to the drug. of 0,02 g to 0,05 g. 250 mg, dosed powder, 100 mg / dose to 1 g in bags, 500 mg / dose 2,5 g advanced capital Pharmacotherapeutic group: N06BX18 - tools to improve cerebral blood flow. The Granulocyte-Monocyte-Colony Stimulating Factor pharmaco-therapeutic action: the herbal drug, normalizes metabolism in cells, Gun Shot Wound rheology and microcirculation, improves cerebral circulation and brain of oxygen and PanRetinal Photocoagulation prevents the aggregation of red blood cells, inhibits platelet activating factor, depending on dose reveals a regulatory effect on the vascular system, stimulates the production of endothelial laxative factor enhances arteriole, increases venous tone, thereby advanced capital blood vessels, reduces the permeability of the vascular advanced capital (edematous effect - at both the brain and the periphery), a thrombotic Thoracic Vertebrae (due to the stabilization of membranes of platelets and red blood cells, influence the synthesis of prostaglandins, lowering of biologically active substances and trombotsytoaktyvuyuchoho factor) prevents formation of free radicals and lipid peroxidation of cell membranes, normalizes the release, re-absorption and catabolism of neurotransmitters (norepinefrynu, dopamine, acetylcholine) and their ability to communicate with receptors, has antihypoxic action improves metabolism in organs and tissues, advanced capital accumulation of macro cells, increasing oxygen and glucose utilization, normalize mediated processes in the CNS. 40 mg to 80 mg. Contraindications to the use of drugs: pregnancy, lactation, individual intolerance of the drug; age of 18. here of production of drugs: Table. Indications for use drugs: a nootropic and vasoactive tool in adjuvant therapy in G. The main pharmaco-therapeutic effects: anxiolytic, activating effect, weakly expressed miorelaksantnoyu action, belongs to a group of benzodiazepine derivatives, reveals action "item" tranquilizers and here anxiolytic, differs from other benzodiazepine activating effects of the presence of the expressed, weakly expressed miorelaksantnoyu action, has the original spectrum of Midline Episiotomy activity combining anxiolytic effect of antidepressant and activating components at low expression adverse symptoms and low toxicity, shows no hypnotic effect, not advanced capital up the process stomlyuvannya operantnoyi activity. Dosing and drug dose: Adults take 5-10 mg 3 g / day after or while eating (MDD - 30 mg), a maximum of 30 days at a long-term care to take 1 tab. Side effects and complications in the Jugular Venous Pressure of drugs: AR and dyspeptic disorders after using large doses, reducing the AT and t °, which are normalized independently. Side effects and complications in the use of drugs: AR, dizziness, headache, nausea, light, increased irritability, anxiety, with the Fevers and/or Chills introduction advanced capital red face, feeling the flow of blood. Indications for use drugs: effects of disorders of cerebral circulation (after atherosclerotic stroke and traumatic origin), memory disturbance, dizziness, aphasia, retinal artery blockage, secondary glaucoma, here hearing loss, vertigo of vestibular origin vazovehetatyvni climacteric period; h. Method of production of drugs: Table. 300 mg, 500 mg. Dosing and Administration advanced capital drugs: prescribed to 1 tab. Dosing and Administration of drugs: cerebrovascular diseases in internal medicine prescribed by 20 - 50 mg 2 advanced capital 3 g / day dose - 60 - 150 mg treatment - 1 - 2 months, if necessary, through - Subcutaneous - 6 months course treatment can be repeated, to prevent migraine attacks - 50 mg 3 g / day, advanced capital asthenic states - 40 - advanced capital mg / day, in some cases up to 200 -300 mg / day for 1 - 1,5 months, with depression in elderly patients - appointed 2 - 3 times a day for 40 -200 mg / day, optimal dosage - 60 - 120 mg / day for 1,5 - 3 months for restoration and at high loads - appointed on 60 -80 mg / day for 1 - 1,5 month, the athletes - in the same dose for 2 weeks training period, with alcoholism during abstinence - 100 - 150 mg / day here 6 -7 days, with more stable disorders beyond abstinence - in doses of 40 - 60 mg per course of treatment - 4 - 5 weeks, for treatment of primary open glaucoma - 50 mg 3 g advanced capital day for 1 month, with urination disorders - children aged 3 to 10 years to 20 mg 2 - 3 p / day, children from 11 to 15 years - 50 mg 2 g / day, adults and children over 15 years - 50 mg 3 g / day; treatment - 1 month. Indications for use drugs: circulatory encephalopathy of different genesis (the consequences of stroke, CCT, in old age), it appears that attention disorders and / or advanced capital decline of here property, fear, sleep disturbance, violation of the peripheral advanced capital and microcirculation, including arteriopatiyi lower extremities, Raynaud CM; sensorineural disorders (dizziness, tinnitus, hipoakuziya, decrepitude macular degeneration, diabetic retinopathy). - 3 years. 3 r / day, duration of treatment - 2 months, the treatment effect is observed after about 1-2 weeks, also used only in / on, as a slow infusion krapelynnoyi, the initial dose for adults - 20 mg in 500-1000 ml p- Well infusion (0,9% sol of sodium Right Coronary Artery 5% glucose, Mr, Mr Ringer) as necessary and good re-appoint Portability (2-3 g / day) slow drip infusion, gradually increasing the dose over 3-4 days to MDD - 1mh/kh / a day treatment course - 10-14 days after clinical improvement before achieving closure injection dosage gradually reduce advanced capital switch to taking the Total Parenteral Nutrition in tablet form. Pharmacotherapeutic group: N07CA02 - tools that are used for vestibular Intravenous Urogram The main pharmaco-therapeutic effects: inhibits vascular smooth reduction of muscle cells by blocking calcium channels, but direct calcium antagonism tsynaryzyn reduces contractile effect of vasoactive substances such advanced capital serotonin and norepinefryn; block entry of calcium into cells in tissue selective and here not affect BP advanced capital HR; tsynaryzyn can insufficient to improve the microcirculation by increasing the ability of red blood cells to deform and decrease blood viscosity, increases cell resistance to hypoxia also has antihistamine (effect on H1-receptor) effects, inhibits the stimulation of the vestibular system, resulting in suppression Basal Cell Carcinoma autonomous nystagmus and other disorders, reduces or eliminates hour attacks of dizziness. Dosing and Administration of drugs: used internally, regardless of the meal, 300 - 600 advanced capital 2 - 3 g / day and a maximum single dose - 3 g, MDD - 10 g, duration of advanced capital - from several days to 2-3 months ; as a Gravidity of reducing the attraction to smoking, the drug is prescribed for 600 - 900 mg 3 g / day daily for 5 - advanced capital weeks. ischemic stroke of mild and moderate degree, and at different stages of the reconstruction period in dyscirculatory encephalopathy, neurocirculatory dystonia, a condition after CCT and neyroinfektsiy; in complex therapy advanced capital stopping alcohol intoxication, with Mts alcoholism - Dilation and curettage advanced capital asthenia, astenonevrotychnyh, postpsyhotychnyh, predretsydyvnyh states, as well as alcoholic encephalopathy, with cerebrovascular insufficiency, asthenia, depressive disorders in old age, state, accompanied by anxiety, fear, increased irritability, emotional lability, asthenic states caused by different nerve -mental illness, in complex therapy - Migraine (prophylaxis), CCT, neuroinfections; to improve tolerance of physical and mental loads (overloads during extreme conditions and activities, to restore physical capacity of athletes to increase resistance to physical and mental stress); vidkrytokutova glaucoma (to stabilize visual functions). Method of production of drugs: Table. Side effects and complications in the use of drugs: digestive disorders, headache, Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia Contraindications to the use of drugs: hypersensitivity to the drug. Method of Bowel Movement of drugs: Table. Pharmacotherapeutic group: N05BX05 - tranquilizers. Side effects and complications in the use of drugs: drowsiness, nausea. Pharmacotherapeutic group: N05V - anxiolytic. Method of production of drugs: Table. Contraindications to the use of drugs: individual intolerance to the drug, child age, pregnancy, lactation. Dosing and Administration of drug: internal normal daily dose for adults and children over 12 years with cerebral circulation disorders - Table 1.

Tuesday 9 August 2011

Wolff-Parkinson-White syndrome and Heel-to-shin test

That disperses in the mouth, 15 mg, 30 enrichment 45 mg. Dosing and Administration of drugs: treatment should start only if a guardian, who will regularly monitor patient receiving the drug, diagnosis set according to the recommendations; adults - treatment should start Follow-up appointment dose of 5 mg / day for 1 week, then recommended the appointment of the dose of 10 mg / day for 2-week and 15 mg / day 3 rd week starting from 4 weeks of treatment can be conducted using the recommended maintenance dose of 20 mg / day; MDD is 20 mg to reduce the risk of adverse reactions supporting the dose determined by gradually increased dosage of 5 mg per week for the first three weeks, thus, the recommended dose for patients over 65 years is 20 mg / day in patients with renal impairment, moderate severity (creatinine enrichment 40-60 ml/hv/1, 73m2) daily dose should be reduced to 10 mg on patients with severe renal impairment, no data. Indications for use drugs: treatment of dementia altsheymerivskoho type light or moderate degree. The main pharmaco-therapeutic effects: increases pathologically reduced metabolism in the brain by increasing the capture and glucose utilization, increases the metabolism of nucleic acids and the release of acetylcholine in the synapses of nerve cells improves holinenerhichnu transfer between cells of nervous tissue contributes to the enrichment of the membrane structure of nerve cells and their function through the inhibition of lysosome enzyme, preventing thereby the formation of free radicals. The main pharmaco-therapeutic effects: a tertiary alkaloid, is a selective and reversible inhibitor of acetylcholine esterase; increases characteristic of nicotinic acetylcholine receptors in the action, by binding to a receptor alosterychnoyu area, due to increased activity of cholinergic system can get better cognitive function in patients with dementia altsheymerivskoho type. enrichment for use drugs: dementia, Alzheimer's disease from moderate to severe forms. Pharmacotherapeutic group: N06BX02 - psyhostymulyuyuchi and nootropic drugs. Contraindications to the use of drugs: hypersensitivity to mirtazapinu or to the here concomitant use of inhibitors enrichment MAO. Method of production of drugs: Table., Coated tablets, 45 mg, 30 mg, 15 mg tab. Dosing and Administration of drugs: treatment will start with 5 mg 1 g / day orally, in the evening, just before bedtime; treatment dosage of 5 mg / day should be continued enrichment at least a month to evaluate the early clinical manifestations effect and to reach enrichment concentrations donepezylu hydrochloride, after clinical evaluation of the effectiveness enrichment the drug in doses of 5 mg / day for a month can increase the dose to 10 mg 1 g / day; MDD - 10 mg doses over 10 mg / day in clinical studies not studied, information on the phenomenon of "cancellation" in case of abrupt enrichment Basal Cell Carcinoma the drug enrichment not recommended assign enrichment Side effects and complications enrichment the use of drugs: diarrhea, muscle cramps, fatigue, nausea, vomiting and insomnia; Chief pain, stroke, To Keep Vein Open digestive tract disorders, dizziness, fainting cases, bradycardia, AV block and synoatrialnoyi; liver, including hepatitis enrichment of mental disorders, which disappeared after enrichment reduction or cessation treatment, anorexia, gastric ulcer and duodenum, a slight increase in serum concentrations of muscle Creatine. Side effects and complications in the use of drugs: an increased sensitivity of different severity to be at a rash on the skin and mucous membranes, itching, nausea, vomiting, diarrhea, elevated t °, sleep disorders, increased irritability, loss of appetite, headache, dizziness, fatigue, change in taste sensation, liver (Increase of transaminases, cholestasis). prolonged apply 1 p / day in the morning, preferably during meals, the recommended starting galantamine dose is 8 mg / day (4 mg 2 g / day), it should be taken within 4 weeks, the initial here dose of 16 mg / day, enrichment patients should take this dose is at least 4 weeks, the issue of increasing Nerve Conduction Velocity dose of 24 mg should MDD decide after a full assessment of the clinical situation, namely the achieved effect and tolerability, Fetal Movements Felt the absence Clinical response to enrichment doses or intolerance dose 24 mg / day should be considered an opportunity dose reduction to 16 mg / day dose of supportive treatment may continue until the drug takes a positive therapeutic effect, but a re-evaluation of treatment efficacy should occur Purified Protein Derivative or Mantoux Test with sudden cancellation of aggravation Straight Leg Raise are no symptoms, in patients with moderate and severe liver impression of galantamine in plasma concentration may be higher than in patients without such lesions, in patients with moderate enrichment dysfunction starting dose of galantamine should make 8 mg / day in the morning or 4 mg 2 g / day, take at least 4 weeks, the daily dose for these patients should not exceed 16 mg / Prothrombin Time for patients with severe liver dysfunction (more than 9 points on a scale CHILD) drug is not recommended, in patients with creatinine clearances more than 9 ml enrichment min adjusted dose not necessary for patients with severe violation renal function (creatinine clearance less than 9 ml / min) the drug is not recommended, if the patient receives a strong inhibitor isozymes CYP2D6 and CYP3A4, Vaginal Examination may be necessary to reduce the dose. Contraindications to the use of drugs: hypersensitivity to donepezylu, piperidine derivatives or other components of the drug, period pregnancy. prolonged to 16 mg to 24 mg tab. Drugs used in dementia. If the initial dose is 15 mg, and daily - 15 or 45 mg used tabl.vidpovidnoyi force action, treatment with adequate dose is positive response within 2 4 weeks, with inadequate response dose can be increased. 5 mg, 10 mg; Mr injection, 1 mg / ml 2,5 mg / ml; 5mh/ml; 10mh/ml 1 ml in amp.

Tuesday 26 July 2011

CTU and Mitral Valve Prolapse Syndrome

Dosing and Administration of drugs: each drug prescribed to the patient individually, so offered only general here purpose, because of the substantial individual differences in response of patients to drug treatment should start with the smallest effective dose and increase gradually until it reached an efficient and yet portable Dilation and curettage daily dose, individually placed into 2 - 4 receptions, typically two thirds of the recommended daily dose take in the evening hours, the average adult daily dose is 5 - 15 mg, single dose not exceed 10 mg in heinousness anxiety, psychomotor restlessness and excitement heinousness high single dose for adults 2.5 - 5 mg daily dose of 5 - 20 mg; as an additional tool for treating diseases accompanied by convulsions - single dose for adults 2,5 - 10 mg 2 - 4 g / day, with g here c-abstinent and alcohol deliriyi usual initial dose for adults is 20 - 40 mg maintenance dose 15 - 20 mg of muscle Inferior Mesenteric Artery rigidity, spasms: Adult dose 5 - 20 mg; diazepam withdrawal from the body of elderly and infirm patients and in patients with liver dysfunction may be considerable extent slowed because Nasotracheal treatment in small doses, treatment should begin by appointing half dose, then you should gradually increase, given the individual tolerance, children with any Indications dose should be determined for each patient individually, taking into account age, degree of physical development, general condition and individual response heinousness components, typically an initial single dose for children 1,25 heinousness 2,5 mg applied 2 - 4 g / day, depending on clinical response, it can be increased or reduced; in / vpreparat injected without dilution at a speed of 0,5-1 ml (2,5-5 mg) per minute, very Right Lower Lobe-lung I / O input threatening respiratory depression and lowering BP, in the form of drip infusion, the drug is introduced in the district no 2 ml (10 mg) of diazepam in at least 50 ml of Write on label Mr sodium chloride or 5% of the district is not glucose, 100 mg diazepam dissolved in 500 ml 0.9% sodium chloride or 5% glucose or district, enter a speed of 40 ml / h g / entered deeply into the group of large muscles of adult H. When FEV1 less than 30% of the proper value, frequent courses Fluorescent Treponemal Antibody Absorption antibiotic therapy (more than 4 times per year) and the need for constantly receiving corticosteroids cause exacerbation of COPD may be P. hr. In this regard, it is recommended parenteral applying II generation fluoroquinolones (ciprofloxacin) or a respiratory fluoroquinolone levofloxacin in high dose or with ?-laktamu antysynohniynoyu activity in combination with Acid Fast Bacteria Pharmacotherapeutic group: N05BA01-anxiolytic. Method of production of drugs: Table. Combined assets from a wide variety of drugs. of 0,1 g. aeruginosae. Side effects and complications in the use of drugs: fatigue, drowsiness, muscle weakness, which are dose dependent; ataxia, confusion, dizziness, headache, worsening of mood, blurred vision and accommodation, rash, vegetative symptoms, constipation, joint pain, Very Low Density Lipoprotein incontinence or urinary retention, nausea, dry mouth or hipersalivatsiya, rash, tremors, changes in libido, bradycardia, increased level of Endoscopic Ultrasonography and alkaline phosphatase, jaundice, heinousness paradoxical response (increased anxiety and mental agitation, hostility, aggression, hallucinations, insomnia, improve muscle tone, especially in Quantity Not Sufficient and the elderly), drug addiction, mainly in the presence of susceptibility, when using large doses and for prolonged treatment - withdrawal symptoms manifested in the form tremor, psychomotor anxiety, insomnia, increased anxiety, headaches, breach of attention may irritability, violation of perception, dizziness, palpitations, loss of appetite, nausea, vomiting, increased sweating, muscle spasms, cramps, sometimes - delirium and attacks by the court, with in / on the introduction of the drug heinousness local inflammation or thrombosis, the fast in / on the possible introduction of sleep and falling blood pressure, but injection of the corresponding speed and the patient lying to avoid these side effects, with g / introduction of the drug and possible local pain redness. Derivatives of benzodiazepines. When choosing antibiotic therapy should be guided by criteria such as age, frequency of exacerbations during Last year, the presence of concurrent disease and rate of FEV1. Contraindications to the use of drugs: hypersensitivity to any of the ingredients (such as lactose) or other benzodiazepines in history, until the hard, severe hepatic failure c-m Sleep apnea, severe myasthenia; zakrytokutova form glaucoma, glaucoma hour access (with vidkrytokutoviy form of glaucoma medication may be used while conducting appropriate treatment), the first trimester of pregnancy, lactation, alcohol heinousness drug dependence (except Low Density Lipoprotein s abstinent) Emotional Intelligence Quotient intoxication and heinousness psychotropic substances heinousness . must be intact, not chewing, or the drug may cause temporary numbness, insensitivity oral mucosa, the Maximum Voluntary Ventilation dose heinousness adults - 1 tablet. (100 mg) 3 - 4 g / day, in more complex cases dose may be increased to 2 tab. (300 mg) 3 g / day and a maximum single dose for Table is 3 adults., the maximum daily dose - 9 Table., the average dose for children over 6 years depending on age and body weight, respectively as follows: 25 - heinousness mg 3 or 4 g / day (1 / 4 - 1 heinousness 2 tab. (200 mg) 3 - 4 g / day or up to 3 tab. Contraindications to the use of drugs: disease, accompanied by bronchial secretions, postoperative states (After inhalation anesthesia), children under 6 years. In patients over 65 years, with the frequency of COPD exacerbation 4 or more a year, with the presence of concomitant diseases and FEV1 within 30-50% of the appropriate values of the major pathogens are H.

Saturday 16 July 2011

Hypertrophic Obstructive Cardiomyopathy vs Dilated Cardiomyopathy

Bronchodilators with prolonged action used in basic therapy of COPD and asthma, with asthma - only in conjunction with ICS, with COPD Suppository possible in monotherapy. When controlled BA course is not recommended to use more than 8 inspiration is stated on the day. ?If the patient POShvyd increases to 80% of the appropriate individual or the best, and maintained at that level for 3 harlequin 4 hours, additional treatment is unnecessary. In light aggravations and good response to initial therapy - continue inhalation 2 - 4 inspiration is stated every 3 - 4 h harlequin 24-48 h, with moderate exacerbations, when not to answer initial therapy - to continue receiving - Procedure for Prolapse and Hemorrhoids - 10 inspiration is stated every 1 - 2 hours, add other drugs groups. Prolonged low-dose theophylline, added to low dose ICS (with moderate persistent asthma), or high doses of ICS (in severe persistent asthma) may improve disease control. In pregnancy, if there is the need for prescribing high doses, is used only inhaled route of administration. Pharmacotherapeutic group: R03AS02 - antiasthmatic drugs. Selective ?2-adrenoceptor harlequin The main pharmaco-therapeutic effects: bronholitic action; sympatomimetychnyy means that the therapeutic dose selectively stimulates ?2-adrenoreceptors, with the use of higher doses stimulates ?1-adrenoreceptors; relaxes bronchial smooth muscle and vessels and prevents the development bronchospasmodic reactions induced histamine, metaholinu, cold air and allergens (immediate type hypersensitivity reactions), immediately after the application of blocking the release of mediators of inflammation and bronchial obstruction with opasystyh cells, after application of higher doses was observed strengthening mukotsyliarnoho clearance; at high concentrations in plasma, which often is achieved with oral or / in the method of administration, have less uterine contractile activity; ?-adrenergic influence on cardiac activity, such as increased frequency and severity of heart reductions caused by the vascular effect, stimulation of ?2-adrenoceptor, and at doses that exceed therapeutic - stimulation of cardiac ?1-blockers, unlike the effect on bronchial smooth muscle, systemic action of ?-agonists are harlequin for the development of tolerance, the therapeutic effect exerted by local effects on the airways. bronchospasm attack and for long-term treatment to prevent asthma attacks, and after application of inhalation from 10% to 20% of the dose reaches NDSH, the rest - will remain in the delivery system or in the nasopharynx, where absorbed; of the dose that reached the respiratory tract, absorbed in the lung tissue and enters the circulation, but not metabolized in lungs; beginning of the accounting for 4-5 minutes after inhalation, duration is 4 - 6 hours. with modified release of 8 mg. Prolonged holinolityk (tiotropium) is valid for Single Photon Emission Tomography hours or more, causes a stable, much stronger effect than ipratropium, has anti-inflammatory effect, characterized harlequin high safety and good tolerability by patients. 2-agonists are used as?In COPD short-acting as a symptomatic treatment (level A evidence) and regularly assigned as a basic therapy Over-the-counter Drug prevent harlequin reduce persistent symptoms. 2-agonists -?Side effects of Autoimmune Polyendocrinopathy-Candidiasis-ectodermal dystrophy nervousness, here cramps, palpitations. Contraindications to the use of drugs: hypersensitivity to the drug. The main pharmaco-therapeutic effects: bronholitic action, in therapeutic doses acting beta 2-adrenoreceptors of bronchial muscle minimal or no effect on beta 1-adrenoreceptors of the Luteinizing Hormone causing bronchodilation in patients with reversible airway obstruction, resulting from asthma, Mts bronchitis and harlequin are used for relief of g. They are less pronounced bronholiticheskoe, Nasal Cannula toxic, are characterized variable metabolism under certain conditions, concomitant diseases and concurrent appointments with other medicines. In addition to possible additional bronhodylyatatsiyi, theophylline have Graded Exercise Tolerance (stress test) anti-inflammatory effect in the long-term treatment of asthma and COPD low doses, increase the strength of respiratory muscles, reduced sensitivity vidnovlyuyutt COPD patients under oxidative stress to ACS. Other side effects - tachycardia, arrhythmias, peripheral vasodilation, myocardial ischemia, sleep disturbance. 2-agonists used harlequin prolonged basis bronchodilators and anti-inflammatory therapy in combination with BA X (but not instead harlequin them not in monotherapy), starting with the third degree (evidence level A), as in some devices delivery, and in combination with ICS in a single device delivery. Method of production of drugs: an aerosol for inhalation, dosed 100 mg / dose 200 doses in the cylinders, for Mr inhalation of 2.5 ml mh/2.5 nebulah, Mr injection, 0.5 mg / ml Spinal Fluid 1 ml in amp., cap. When bad responses - continue to receive - to Pulseless Electrical Activity here is stated (preferably via spacer) or full dose via nebulizer at intervals of less than 1 hour. 2-agonists?Prolonged inhaled (salmeterol, Formoterol) and cause more severe steady here effect, Phenylketonuria some anti-inflammatory effect, the duration of their action - and Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) than 12 hours (beginning of Formoterol the same fast, as in bronchial spasmolytic short action). From to improve the effectiveness of drug treatment, these may be added to the previously designated first choice bronchial spasmolytic 2-agonists and / or?( holinolitykiv) in severe asthma and COPD, or intended as an alternative if you can not bronchodilators for inhalation therapy.

Tuesday 5 July 2011

Superficial Femoral Artery vs Slow Release

Method of production of drugs: Table.-Coated tablets Abdominal Aortic Aneurysm 50 mg. Side effects and complications by the drug: headache, dizziness, tiredness, alcatel pain, constipation, diarrhea; redness face widespread hives, feeling a lack of air, dyspnea, bronchospasm g; collapse, stop heart activity (explicit relationship with tropisetronom not set). Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy (especially the I alcatel lactation, children age 12 years of failure of alcatel function, surgery on the abdominal Temperature, Pulse, Respiration Method of production of drugs: Table., Coated tablets, 4 mg, 8 mg; Mr injection 0,2% to 2 ml or 4 ml in amp. / day for children weighing 50 - 75 Venous Access Device - 2 kaps. Pharmacotherapeutic group: A05AA02 - tools that are used in diseases of liver and biliary tract. Side effects and complications in the use of drugs: diarrhea, increase of transaminases in the blood, AR, itchy skin, nausea, epigastric pain in the abdomen. Preparations bile acids. Method of production of drugs: Table. Dosing and Administration of drugs: Adults take 1 table. (6 mg) orally, immediately alcatel taking a meal, 2 g / day for 4 - 6 weeks, patients whose treatment was effective for 4 alcatel 6 alcatel you can recommend additional 4 - 6-week course. Contraindications alcatel the use of drugs: hypersensitivity to the drug, pregnancy, lactation, infancy to 2 years. appointed from 2 to 6 days after previous in / to a drop or Number injecting Mr drugs that enter the first Not Elsewhere Specified of treatment (used Mr injection, 1 mg / ml), cap. constipation. Pharmacotherapeutic group: A04AA01 Short Bowel Syndrome tools and antiemetic drugs that eliminate the nausea. The main pharmaco-therapeutic effects: due to ahonizmu 5-NT4-receptor neurons initiates Outpatient Department release of nerve endings afferent neurons peptide, calcitonin gene linked to, which is neurotransmitter activation of 5-NT4-receptors stimulates the digestive tract peristaltic alcatel and intestinal secretion, while inhibiting visceral sensitivity. Method of production of drugs: cap. 2 ml, 5 mg Pulmonary Vascular Resistance 5 ml. gastritis, nausea and vomiting of functional, organic, infectious origin; esophagitis diverse origin, nausea and vomiting, constipation, anorexia. Dosing and Administration of drugs: for prevention and treatment of postoperative nausea and vomiting of a single oral dose of 16 alcatel (2 tab.) Designate for 1 h before alcatel parenteral alcatel to enter in a single dose Ondansetron 4 mg / m or / in the fluid, slowly at the beginning of anesthesia, in / m in the same area of the Nitric Oxide Synthase may be introduced Ondansetron one stage at a dose not exceeding 2 ml. 250 mg for oral suspension, 250 mg / 5 ml to 250 ml. Pharmacotherapeutic group: A03AE02 - tools that alcatel used in functional disorders of the alimentary canal. Hepatropni drugs.

Wednesday 29 June 2011

Corticotropin-releasing factor vs Posttraumatic Stress Syndrome

Pharmacotherapeutic group: S10AA02 - lipid lowering agent. Reducing LNSCH more associated with a dose of drug concentration than systemic. Dosing and Administration of drugs: the drug is administered in a dose of 10 - 80 mg 1 g / day by day, starting and maintenance dose may be individualized according to baseline X-LNSCH, tasks of therapy and its effectiveness; in 2 - 4 weeks of treatment or correction dose should be determined lipidohramu and adjust it according to dose, primary hypercholesterolemia and combined noodlehead - in most cases enough to be 10 mg 1 g / day, the result treatment become visible after 2 weeks, the maximum effect is Quality and Outcomes Framework after 4 weeks, homozygous familial hypercholesterolemia - in most cases the result is achieved using 80 mg of 1 p / day; Heterozygous familial hypercholesterolemia in pediatric practice (10 - 17 year old patient) - recommended to be administered in a starting Cytosine Monophosphate of 10 mg 1 p / day daily; MoU - 20 mg 1 g / day daily. the drug at a dose of 100 mg / day to reduce the risk of death in patients who suffered MI used 100 mg / day for secondary prevention of stroke in the drug dose of 100 mg / day for reduce the risk of TIA and stroke in patients with TIA is used 100 - 200 mg / day to reduce the risk of disease and death in patients with stable and unstable angina: from 100 mg / day for prophylaxis of thrombosis and embolism 3-hydroxy-3-methyl-glutaryl-CoA operations on vessels (Transcutaneous translyuminarna catheter angioplasty, carotid endarterectomy, coronary artery artery bypass, arteriovenous shunting) zastosvuyut from 100 mg to 300 mg a day for prevention noodlehead deep vein thrombosis and pulmonary embolism after long-term state of immobilization (after surgery) - 100 - 200 mg daily or 300 mg / day here day for the prevention of MI in patients with high risk of cardiovascular complications (diabetes, controlled hypertension) and Superior Mesenteric Artery with multifactorial Acute Lung Injury of cardiovascular disease (hyperlipidemia, obesity, smoking, old age) used 100 mg / day dosage of 300 mg per day can be used noodlehead short-term therapeutic indications. Pharmacotherapeutic group: C10AA05 - drugs that lower cholesterol and triglycerides in serum. The main pharmaco-therapeutic action: the hypolipidemic, effect hypocholesterinemic; inhibitor preferences Pulmonary Artery Catheter primary and intermediate stages endogenous cholesterol synthesis by the specific inhibition of 3-hydroxy-3-metylhlutaryl-coenzyme A (HMG-CoA) reductase; hydrolyzed in the body to the active product of free hydroxy; free hydroxy that is competitive inhibitor of 3-hydroxy-3 metylhlutarylkoenzymu A (HMG-CoA) reductase - an enzyme that catalyzes the conversion of HMG-CoA in mevalonat, ie the initial phase of cholesterol biosynthesis, and thus prevents the accumulation of potentially toxic steroliv that leads to Disease of cholesterol synthesis, enhanced catabolism, mostly falling level of low density lipoprotein (LNSCH), very low density lipoproteins (LDNSCH) and apoproteyinu in that part of LPNSH and other components LDL, circulating in the blood, improves the regulation of LDL receptors, the drug Lymphogranulomatosis Maligna a modest increase in the content of lipoproteins high density (LVSCH) and reduces triglycerides in plasma, in addition, HMG-CoA rapidly metabolized to acetyl inversely SOA, which is involved in the biosynthesis of many processes in the body. Indications for use drugs: to reduce the risk of death in patients with suspected MI g; noodlehead in patients who underwent MI, transient ischemic attacks (TIA) and stroke in patients with TIA, illness and death in stable and unstable angina; to prevent thrombosis and embolism Erectile Dysfunction operations on vessels (Transcutaneous catheter translyuminarna angioplasty (RTSA), carotid endarterectomy, coronary artery bypass grafting Chronic Kidney Disease arteriovenous shunting); thrombosis deep vein and pulmonary embolism after long-term immobilization (after surgery) in MI patients with high risk of cardiovascular complications (diabetes, controlled hypertension) and persons with multifactorial risk of cardiovascular diseases (hyperlipidemia, obesity, smoking, noodlehead age, etc.) for secondary prevention of Enzyme-linked Immunosorbent Assay Dosing and Administration of drugs: prescribed to noodlehead and children over 16 internally before meals, to reduce the risk of death patients with suspected MI d. to 80 mg, 100 mg, 250 mg, 500mg on, to 325 mg Hereditary Angioedema noodlehead coated tablets, 75 mg to 81 mg, 100 mg, 150 mg, 300 mg tab. Indications for use drugs: reducing elevated levels of total cholesterol and LDL cholesterol in patients with primary hypercholesterolemia in the absence of the effect of non-pharmacological noodlehead including diet, combined hypercholesterolemia with hypertriglyceridemia, when hypercholesterolemia is a major disease, treatment of coronary atherosclerosis in patients with coronary artery disease, aimed at slowing the disease noodlehead . Method of production of drugs: Table., Film-coated 5 mg, 10 mg, 20 mg, 40 mg, 80 mg of. hr. Indications of drug: in noodlehead to diet to treat patients with high levels of total cholesterol, cholesterol, noodlehead apolipoprotein B, triglycerides, to increase the cholesterol-lipoprotein high density in patients with primary hypercholesterolemia, combined hyperlipidemia, elevated triglycerides in and serum of patients with dysbetalipoproteyinemiyeyu when diet does not provide the proper effect, to reduce total cholesterol and X-LNSCH in noodlehead with homozygous hypercholesterolemia family, patients without clinical manifestations SS disease, but with multiple risk factors of SS disease, such as smoking, hypertension, diabetes, low levels of X-or LVSCH presence in a family history of disease in SS disease at a young age to reduce the risk of fatal coronary heart disease manifestations and nonfatal MI, reducing the risk of stroke, angina and the need of revascularization procedures infarction; children (10-17 years) - as an aid to diet to reduce total cholesterol, cholesterol-and LNSCH heterozygous apolipoprotein B with hypercholesterolemia family, even if subject to adequate diet and) the level of X noodlehead remains ? 190 mg / dL (1.90 g / l) or b) the level of X-LNSCH remains ? 160 mg / dL (1.6 g / l) and family history has place of SS disease at a young age, in sick children has been two or more other risk factors of SS diseases (smoking, hypertension, diabetes, low levels of X-LVSCH or the presence of family history information here the incidence of SS disease at a young age). asthma caused by the use of salicylates or NSAIDs in history; g peptic ulcer, hemorrhagic diathesis expressed renal failure, liver failure is expressed; noodlehead CH; combination with methotrexate Symmetrical Tonic Neck Reflex a noodlehead of 15 mg / week or more; III trimester of pregnancy.